These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8024292)

  • 1. Primary immunisations in Liverpool. II: Is there a gap between consent and completion?
    Pearson M; Makowiecka K; Gregg J; Woollard J; Rogers M; West C
    Arch Dis Child; 1993 Jul; 69(1):115-9. PubMed ID: 8024292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary immunisations in Liverpool. I: Who withholds consent?
    Pearson M; Makowiecka K; Gregg J; Woollard J; Rogers M; West C
    Arch Dis Child; 1993 Jul; 69(1):110-4. PubMed ID: 8024291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting uptake of measles, mumps, and rubella immunisation.
    Li J; Taylor B
    BMJ; 1993 Jul; 307(6897):168-71. PubMed ID: 8343745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization coverage and its relationship to preventive health care visits among inner-city children in Baltimore.
    Guyer B; Hughart N; Holt E; Ross A; Stanton B; Keane V; Bonner N; Dwyer DM; Cwi JS
    Pediatrics; 1994 Jul; 94(1):53-8. PubMed ID: 8008538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation state and its documentation in hospital patients.
    Ferson MJ
    Arch Dis Child; 1990 Jul; 65(7):763-7. PubMed ID: 2386382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic immunisation in hospital.
    Conway SP
    Arch Dis Child; 1999 Nov; 81(5):422-5. PubMed ID: 10519717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.
    Roberts RJ; Sandifer QD; Evans MR; Nolan-Farrell MZ; Davis PM
    BMJ; 1995 Jun; 310(6995):1629-32. PubMed ID: 7795447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "KITS" for improved immunization of Kauai children.
    Manea SJ
    Hawaii Med J; 1997 May; 56(5):121-3, 128. PubMed ID: 9188222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective cohort study of risk factors for missing preschool booster immunisation.
    Evans MR; Thomas DR
    Arch Dis Child; 1998 Aug; 79(2):141-4. PubMed ID: 9797595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of a specialist service for advice on childhood immunisation.
    Newport MJ; Conway SP
    J Infect; 1993 May; 26(3):295-300. PubMed ID: 8505563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine.
    Benjamin CM; Chew GC; Silman AJ
    BMJ; 1992 Apr; 304(6834):1075-8. PubMed ID: 1586818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive care for children: immunization in England and Wales.
    Goodwin S
    Pediatrics; 1990 Dec; 86(6 Pt 2):1056-60. PubMed ID: 2243739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Communauté française' eradication plan for measles, mumps and rubella].
    Berghmans L; Swennen B; Dachy A; Reginster R; Thieffry P; Drumaux P
    Arch Belg; 1989; 47(1-4):8-10. PubMed ID: 2610579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary health care and immunisation in Iran.
    Nasseri K; Sadrizadeh B; Malek-Afzali H; Mohammad K; Chamsa M; Cheraghchi-Bashi MT; Haghgoo M; Azmoodeh M
    Public Health; 1991 May; 105(3):229-38. PubMed ID: 2062995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with improved immunization rates for urban minority preschool children.
    Mitchell CK; Franco SM
    Clin Pediatr (Phila); 1995 Sep; 34(9):466-70. PubMed ID: 7586918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open question to those responsible for the measles-mumps-rubella vaccination program].
    Gaillet RP
    Rev Med Suisse Romande; 1988 Aug; 108(8):711-6. PubMed ID: 3187286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.